[HTML][HTML] The promise of circulating tumor DNA (ctDNA) in the management of early-stage colon cancer: a critical review

S Chakrabarti, H Xie, R Urrutia, A Mahipal - Cancers, 2020 - mdpi.com
Simple Summary Currently, the treatment for localized colon cancer consists of surgery and,
if the presence of residual cancer cells is suspected, chemotherapy following the surgery …

[PDF][PDF] The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review

S Chakrabarti, H Xie, R Urrutia, A Mahipal - pdfs.semanticscholar.org
The current standard treatment for patients with early-stage colon cancer consists of surgical
resection, followed by adjuvant therapy in a select group of patients deemed at risk of cancer …

The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review

S Chakrabarti, H Xie, R Urrutia, A Mahipal - Cancers, 2020 - go.gale.com
Currently, the treatment for localized colon cancer consists of surgery and, if the presence of
residual cancer cells is suspected, chemotherapy following the surgery. However, the …

The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review.

S Chakrabarti, H Xie, R Urrutia, A Mahipal - Cancers, 2020 - europepmc.org
The current standard treatment for patients with early-stage colon cancer consists of surgical
resection, followed by adjuvant therapy in a select group of patients deemed at risk of cancer …

The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review

S Chakrabarti, H Xie, R Urrutia, A Mahipal - Cancers, 2020 - search.proquest.com
The current standard treatment for patients with early-stage colon cancer consists of surgical
resection, followed by adjuvant therapy in a select group of patients deemed at risk of cancer …

The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review

S Chakrabarti, H Xie, R Urrutia, A Mahipal - Cancers, 2020 - pubmed.ncbi.nlm.nih.gov
The current standard treatment for patients with early-stage colon cancer consists of surgical
resection, followed by adjuvant therapy in a select group of patients deemed at risk of cancer …

The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review

S Chakrabarti, H Xie, R Urrutia, A Mahipal - Cancers, 2020 - cir.nii.ac.jp
抄録< jats: p> The current standard treatment for patients with early-stage colon cancer
consists of surgical resection, followed by adjuvant therapy in a select group of patients …

[HTML][HTML] The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review

S Chakrabarti, H Xie, R Urrutia, A Mahipal - Cancers, 2020 - ncbi.nlm.nih.gov
The current standard treatment for patients with early-stage colon cancer consists of surgical
resection, followed by adjuvant therapy in a select group of patients deemed at risk of cancer …

The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review.

S Chakrabarti, H Xie, R Urrutia, A Mahipal - Cancers, 2020 - search.ebscohost.com
Abstract Simple Summary: Currently, the treatment for localized colon cancer consists of
surgery and, if the presence of residual cancer cells is suspected, chemotherapy following …

[引用][C] The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review

S Chakrabarti, H Xie, R Urrutia, A Mahipal - Cancers (Web), 2020 - jglobal.jst.go.jp
The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon
Cancer: A Critical Review | Article Information | J-GLOBAL Art J-GLOBAL ID:202102242590750682 …